Follow The Filings

GLUEMonte Rosa Therapeutics Inc.

Q1 2026 13F holders among managers we track Latest ownership dossier

Ticker
GLUE
Type
Equity
Class
COM
Total reported value (long equity)
Manager Report date Value Shares